UiPath Inc (PATH)

UiPath Inc is a New York-based software company listed on the NYSE under the ticker PATH. The company develops an automation platform centered on robotic process automation and related enterprise workflow tools. Its UiPath platform is designed to help AI agents, robots, people, and models work together in coordinated processes. The product suite includes process orchestration and intelligence tools, agent building capabilities, RPA and API automation, intelligent capture and processing, testing and quality assurance software, packaged agentic solutions, and governance features for automations, AI agents, and manual tasks. UiPath serves customers across financial services, healthcare, manufacturing, retail, and the public sector, with operations in the United States, Romania, the United Kingdom, the Netherlands, and other international markets. Founded in 2005, the company operates as a common stock issuer in the information technology sector.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-PATH
$14.81
23.6% Upside
Undervalued
$13.25
10.5% Upside
Fair
Great
0.0%
September 8, 2026
18.8x
3.2x
3.7x
6.3 B
4.838 B
1.3%
79.1%
4.1
114.6%
Valuation • Fair Value

UiPath Inc (NYSE-PATH) Fair Value by Valuation Model

Compare the primary fair value estimate for UiPath Inc (NYSE-PATH) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$14.81

Estimated upside of 23.6% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$15.90

Discounted cash flow valuation reference.

Ben Graham Formula Value

$7.01

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$8.27

Earnings power value estimate.

Comps Fair Value

$14.82

Comparable-company valuation reference.

Analyst Price Target

$13.25

Analysts imply upside of 10.5%.

How to read these valuation models

Use this section to compare the primary fair value estimate for UiPath Inc (NYSE-PATH) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for UiPath Inc (NYSE-PATH)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.672 B

Current operating scale indicator.

Revenue Forecast

1.778 B

Forward revenue estimate.

EBITDA

123.6 M

Current operating profitability reference.

EBITDA Forecast

450.9 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review UiPath Inc (NYSE-PATH) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for UiPath Inc (NYSE-PATH)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

8

Relatively strong quality score.

Beneish M-Score

-2.14

Intermediate zone that deserves monitoring.

Altman Z-Score

4.1

Relatively strong balance-sheet zone.

FCF / Net Income

114.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for UiPath Inc (NYSE-PATH). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for UiPath Inc (NYSE-PATH)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 8, 2026

Days to Earnings

49

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for UiPath Inc (NYSE-PATH), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

UiPath Inc (NYSE-PATH) Stock Forecast & Technical Outlook

Review UiPath Inc (NYSE-PATH) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for UiPath Inc (NYSE-PATH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for UiPath Inc (NYSE-PATH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for UiPath Inc (NYSE-PATH) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for UiPath Inc (NYSE-PATH) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for UiPath Inc (NYSE-PATH) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for UiPath Inc (NYSE-PATH)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, UiPath Inc (NYSE-PATH) has a Hold consensus, with 2 buy, 16 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 16
Sell 0
FAQ Fast Investor Answers

UiPath Inc (NYSE-PATH) Stock FAQ

Quick answers about UiPath Inc (NYSE-PATH) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$14.81
Estimated upside 23.6%
Valuation Rating
Undervalued
Estimated upside of 23.6%
Analyst Target
$13.25
Implied upside 10.5%
Financial Health
Great
Current financial-health read

The current fair value estimate for UiPath Inc (NYSE-PATH) is $14.81. This implies an estimated upside of 23.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 23.6% versus the current market price.

The available analyst price target for UiPath Inc (NYSE-PATH) is $13.25. The analyst target implies estimated upside of 10.5%.

The current financial health read for UiPath Inc (NYSE-PATH) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for UiPath Inc (NYSE-PATH) is September 8, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for UiPath Inc (NYSE-PATH) is 18.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for UiPath Inc is 6.3 B.

The current enterprise value listed for UiPath Inc is 4.838 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for UiPath Inc is NYSE-PATH, and the stock is listed on NYSE.

UiPath Inc (NYSE-PATH) is listed on NYSE.

The current debt-to-total-capital ratio listed for UiPath Inc is 1.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for UiPath Inc is 79.1%. Free float helps investors understand how much of the share base is available for public trading.